Global Burden of Head and Neck Cancers from 1990 to 2019

Overview

Journal iScience

Publisher Cell Press

Date 2024 Mar 8

PMID 38455975

Authors

Tianjiao Zhou

Weijun Huang

Xiaoting Wang

Jingyu Zhang

Enhui Zhou

Yixing Tu

Jianyin Zou

Kaiming Su

Hongliang Yi

Shankai Yin

Affiliations

Soon will be listed here.

Abstract

Head and neck cancer (HNC) exerts a significant healthcare burden worldwide. Insufficient data impedes a comprehensive understanding of its global impact. Through analysis of the 2019 Global Burden of Disease (GBD) database, our secondary investigation unveiled a surging global incidence of HNC, yet a decline in associated mortality and disability-adjusted life years (DALYs) owing to enhanced prognosis. Particularly noteworthy is the higher incidence of escalation among females compared to males. Effective resource allocation, meticulous control of risk factors, and tailored interventions are imperative to curtail mortality rates among young individuals afflicted with HNC in underprivileged regions, as well as in elderly individuals grappling with thyroid cancer.

Citing Articles

Mortality of Head and Neck Cancer in China From 1990 to 2019: A Secondary Data Analysis.

Zhu Z, Yuan J, Fu L, Zhang W, Liu S, Liu Y Cancer Rep (Hoboken). 2025; 8(3):e70116.

PMID: 40071521 PMC: 11897804. DOI: 10.1002/cnr2.70116.

Mast cell - tumor cell interaction related gene and microRNA expression profiles in oral squamous cell carcinoma.

Khromov T, Sitte M, Salinas G, Schminke B, Fischer A, Schliephake H Front Oncol. 2025; 15:1518404.

PMID: 40061903 PMC: 11885139. DOI: 10.3389/fonc.2025.1518404.

VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival.

Gormley M, Adhikari A, Dudding T, Pring M, Hurley K, Macfarlane G medRxiv. 2025; .

PMID: 40034767 PMC: 11875266. DOI: 10.1101/2025.02.17.25322399.

Global trends and risk factors of laryngeal cancer: a systematic analysis for the Global Burden of Disease Study (1990-2021).

Zhou T, Wang X, Zhu Q, Zhou E, Zhang J, Song F BMC Cancer. 2025; 25(1):296.

PMID: 39972455 PMC: 11837445. DOI: 10.1186/s12885-025-13700-4.

An ensemble machine learning-based performance evaluation identifies top In-Silico pathogenicity prediction methods that best classify driver mutations in cancer.

Das S, Patel V, Chakravarty S, Ghosh A, Mukhopadhyay A, Biswas N BioData Min. 2025; 18(1):7.

PMID: 39833905 PMC: 11744934. DOI: 10.1186/s13040-024-00420-x.

References

Raudenska M, Balvan J, Masarik M . Cell death in head and neck cancer pathogenesis and treatment. Cell Death Dis. 2021; 12(2):192. PMC: 7893032. DOI: 10.1038/s41419-021-03474-5. View

Panth N, Simpson M, Sethi R, Varvares M, Osazuwa-Peters N . Insurance status, stage of presentation, and survival among female patients with head and neck cancer. Laryngoscope. 2019; 130(2):385-391. DOI: 10.1002/lary.27929. View

van Tilburg L, van de Ven S, de Jonge P, de Graaf W, Spaander M, Nikkessen S . Endoscopic screening of the upper gastrointestinal tract for second primary tumors in patients with head and neck cancer in a Western country. Endoscopy. 2023; 55(11):981-990. PMC: 10602659. DOI: 10.1055/a-2111-5935. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Lin L, Li Z, Yan L, Liu Y, Yang H, Li H . Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019. J Hematol Oncol. 2021; 14(1):197. PMC: 8607714. DOI: 10.1186/s13045-021-01213-z. View

Tota J, Giuliano A, Goldstone S, Dubin B, Saah A, Luxembourg A . Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial. Clin Infect Dis. 2021; 74(7):1247-1256. DOI: 10.1093/cid/ciab603. View

. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022; 400(10347):185-235. PMC: 9289789. DOI: 10.1016/S0140-6736(22)00847-9. View

Huang J, Chan S, Ko S, Lok V, Zhang L, Lin X . Updated disease distributions, risk factors, and trends of laryngeal cancer: a global analysis of cancer registries. Int J Surg. 2023; 110(2):810-819. PMC: 10871644. DOI: 10.1097/JS9.0000000000000902. View

Guo K, Xiao W, Chen X, Zhao Z, Lin Y, Chen G . Epidemiological Trends of Head and Neck Cancer: A Population-Based Study. Biomed Res Int. 2021; 2021:1738932. PMC: 8294963. DOI: 10.1155/2021/1738932. View

10.

Zumsteg Z, Luu M, Rosenberg P, Elrod J, Bray F, Vaccarella S . Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst. 2023; 115(12):1544-1554. PMC: 10699798. DOI: 10.1093/jnci/djad169. View

11.

Cohen E, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn M . Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet. 2018; 393(10167):156-167. DOI: 10.1016/S0140-6736(18)31999-8. View

12.

Manthey J, Shield K, Rylett M, Hasan O, Probst C, Rehm J . Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019; 393(10190):2493-2502. DOI: 10.1016/S0140-6736(18)32744-2. View

13.

Leoncini E, Vukovic V, Cadoni G, Giraldi L, Pastorino R, Arzani D . Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium. Eur J Epidemiol. 2018; 33(12):1205-1218. PMC: 6290648. DOI: 10.1007/s10654-018-0409-5. View

14.

Giannone G, Giuliano A, Bandini M, Marandino L, Raggi D, Earle W . HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage. Cancer Treat Rev. 2022; 111:102467. DOI: 10.1016/j.ctrv.2022.102467. View

15.

Hashim D, Sartori S, La Vecchia C, Serraino D, Dal Maso L, Negri E . Hormone factors play a favorable role in female head and neck cancer risk. Cancer Med. 2017; 6(8):1998-2007. PMC: 5548879. DOI: 10.1002/cam4.1136. View

16.

Miranda-Galvis M, Loveless R, Kowalski L, Teng Y . Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression. Cells. 2021; 10(2). PMC: 7917998. DOI: 10.3390/cells10020389. View

17.

Lehtinen M, Baussano I, Paavonen J, Vanska S, Dillner J . Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies. Expert Rev Vaccines. 2019; 18(2):153-160. DOI: 10.1080/14760584.2019.1568876. View

18.

Papaleontiou M, Norton E, Reyes-Gastelum D, Banerjee M, Haymart M . Competing Causes of Death in Older Adults with Thyroid Cancer. Thyroid. 2021; 31(9):1359-1365. PMC: 8591088. DOI: 10.1089/thy.2020.0929. View

19.

Chow L . Head and Neck Cancer. N Engl J Med. 2020; 382(1):60-72. DOI: 10.1056/NEJMra1715715. View

20.

Guo Y, Luo Y, Zhang Q, Huang X, Li Z, Shen L . First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial. Eur J Cancer. 2021; 156:35-45. DOI: 10.1016/j.ejca.2021.06.039. View